RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $851,000 | -27.0% | 321,100 | 0.0% | 0.02% | -11.5% |
| Q3 2021 | $1,166,000 | -16.4% | 321,100 | 0.0% | 0.03% | -7.1% |
| Q2 2021 | $1,394,000 | +27.0% | 321,100 | 0.0% | 0.03% | +47.4% |
| Q1 2021 | $1,098,000 | -2.3% | 321,100 | 0.0% | 0.02% | -20.8% |
| Q4 2020 | $1,124,000 | +45.8% | 321,100 | 0.0% | 0.02% | +26.3% |
| Q3 2020 | $771,000 | +24.6% | 321,100 | -5.0% | 0.02% | +11.8% |
| Q2 2020 | $619,000 | +13.4% | 338,000 | -3.4% | 0.02% | -26.1% |
| Q1 2020 | $546,000 | – | 350,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |